These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
715 related items for PubMed ID: 19953334
1. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications. Haferkamp A, Kurosch M, Pritsch M, Hatiboglu G, Macher-Goeppinger S, Pfitzenmaier J, Pahernik S, Wagener N, Hohenfellner M. Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334 [Abstract] [Full Text] [Related]
2. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients. Becker F, Siemer S, Humke U, Hack M, Ziegler M, Stöckle M. Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779 [Abstract] [Full Text] [Related]
10. Long-term outcomes after nephron sparing surgery for renal cell carcinoma larger than 4 cm. Peycelon M, Hupertan V, Comperat E, Renard-Penna R, Vaessen C, Conort P, Bitker MO, Chartier-Kastler E, Richard F, Rouprêt M. J Urol; 2009 Jan; 181(1):35-41. PubMed ID: 19012929 [Abstract] [Full Text] [Related]
13. The influence of body mass index on the long-term survival of patients with renal cell carcinoma after tumour nephrectomy. Haferkamp A, Pritsch M, Bedke J, Wagener N, Pfitzenmaier J, Buse S, Hohenfellner M. BJU Int; 2008 May; 101(10):1243-6. PubMed ID: 18261150 [Abstract] [Full Text] [Related]
14. Application of TNM, 2002 version, in localized renal cell carcinoma: is it able to predict different cancer-specific survival probability? Ficarra V, Novara G, Galfano A, Novella G, Schiavone D, Artibani W. Urology; 2004 Jun; 63(6):1050-4. PubMed ID: 15183948 [Abstract] [Full Text] [Related]
15. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy. Leibovich BC, Blute M, Cheville JC, Lohse CM, Weaver AL, Zincke H. J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272 [Abstract] [Full Text] [Related]
16. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [Abstract] [Full Text] [Related]
17. Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view. May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S. Urol Oncol; 2010 Jul; 28(3):274-9. PubMed ID: 18805709 [Abstract] [Full Text] [Related]